Levodopa

Research use only, not for human use.

L-DOPA is a natural form of DOPA used in the treatment of Parkinson disease.

L-DOPA is a natural form of DOPA used in the treatment of Parkinson disease. L-DOPA  is the precursor of dopamine and product of tyrosine hydroxylase.

——

Animal Model:7-week-old C57BL/6J mice Dosage:20 mg/kg Administration:Orally Result:Reduced Rotenone-induced motor dysfunction.Animal Model:Sprague-Dawley rats (male 100-150 g) Dosage:10, 30, 50, 70, and 100 mg/kg Administration:Orally Result:Reverses tactile, cold and heat allodynia in neuropathic rat without any side effect.

3,4-Dihydroxyphenylalanine | Levodopa

GPCR/G Protein

Dopamine Receptor

Dopamine

Neurological Disease

——

59-92-7

197.19

C9H11NO4

>98% (HPLC)

Ethanol: <1 mg/mL (<1 mM); Water: <1 mg/mL (<1 mM); DMSO: <1 mg/mL (<1 mM)

C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O

——

(-20℃)

With Ice Pack

≥ 2 years